Trends and New Technology in Vaccine Manufacturing

摘要

Significant changes are sweeping the vaccine manufacturing industry. Demand for human vaccines is predicted to grow significantly — in part driven by needs in emerging countries, where only small fractions of their large and growing populations has access to vaccines. Sustained growth is expected to yield a vaccine market of US$25 billion by the year 2015 (l). Relatively low immunization rates in the Asia-Pacific regions represent significant untapped potential for vaccine manufacturers. Growing populations, increased government funding, and increasing personal wealth leads to more money being spent on improving personal health overall. Estimates of vaccine growth /range as high as 65% in the Asia-Pacific. Significant vaccine-related investments are flowing into the region as many industry leaders establish research and development centers and expand their Asia—Pacific manufacturing capacity. China's National Development and Reform commission is partially sponsoring investments and notes that development of new vaccines is the "number one project" in the biopharmaceutical industry.